4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING
|
|
- Beverly Horton
- 6 years ago
- Views:
Transcription
1 Opioid Use Disorder in Pregnancy 2017 Recommendations from ACOG and The Pew Charitable Trust KATHY D. HARTKE, MD, LEGISLATIVE CO-CHAIR AND IMMEDIATE PAST CHAIR, WISCONSIN SECTION OF THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS, BROOKFIELD, WI DISCLOSURES No financial disclosures Expert witness in the in the United States District Court for the Western District of Wisconsin Tamara M. Loertscherv. Eloise Anderson, Brad Schimel, Taylor County Testified in Racine County Court 1996 Opioid Addiction Resources - OBJECTIVES March 16, 2018 Drug Enforcement Administration Review key points on Obstetric Care for Women With Opioid Use (Patient Safety Bundle) Discuss research on safer opioid prescribing Present 2018 ACOG and Pew Charitable Trust policy recommendations U.S. Centers for Disease Control and Prevention (CDC) - 63,632 drug overdose deaths in the United States in deaths per day - One death every 8.28 minutes - 42,249 (66.4%) of those deaths were due to opioids. ANTENATAL TESTING Lack of evidence for OUD alone Only if other clinical indications eg. growth restriction Perform at least 4-6 hours after daily maintenance methadone dose Anatomy Ultrasound screening at week Serial fetal growth assessment Vol 130, No. 1, July 2017 Obstetrics and Gynecology 1
2 Multidisciplinary Care KEY GAPS IN KNOWLEDGE Training of health care providers in a manner that fosters multidisciplinary care and crosses specialty area boundaries is needed to provide optimal care COMMUNICATE WITH MAT PROVIDER NEONATOLOGY OBSTETRIC Optimal screening, treatment and care throughout pregnancy and pp Elective medically supervised withdrawal during pregnancy NEONATAL New scoring tool, incorporates neurobehavioral assessment Optimal approaches to nonpharmacologic and pharmacologic rx ANESTHESIOLOGY GENETICS Inherited genetic variations in opioid action and metabolism ACOG COMMITTEE OPINION #711 August 2017 Opioid Use and Opioid Use Disorder in Pregnancy Early universal screening, brief intervention and referral for treatment Use validated screening tools For chronic pain minimize opioids. Use alternatives such as exercise, PT, behavioral approaches and nonopioid pharmacologic treatments Opioid agonist pharmacotherapy is recommended over medically supervised withdrawal. ACOG Committee Opinion POSTPARTUM PSYCHOSOCIAL SUPPORT ONGOING SUD TREATMENT MENTAL HEALTH SCREENING AND SUPPORT FOURTH TRIMESTER FIRST POSTPARUM VISIT AT 1 WEEK Breastfeeding should be encouraged CONTRACEPTION Contraception Counseling and access to contraceptive services should be available to all women of reproductive age Should be a routine part of substance use disorder treatment Offer Immediate Post Partum (IPP) contraception 86% of pregnancies in women with OUD unintended 29% of women report 6 or more pregnancies 6% report 10 or more pregnancies 25-75% of women with OUD report no contraceptive use 2/3 of women who use contraception using condoms 2
3 MULTIDISCIPLINARY APPROACH COMMUNICATE WITH MAT PROVIDER NEONATOLOGY ANESTHESIA Opioid Epidemic: Original Research Patterns of Opioid Prescription and Use After Cesarean Delivery Brian Bateman et al. Massachusetts General, Harvard Medical School VOL. 130, NO. 1, JULY 2017 OBSTETRICS & GYNECOLOGY 720 women enrolled 615 (85.4%) filled an opioid prescription Median Number of pills dispensed 40 (interquartile range 30-40) Median Number of pills consumed 20 (interquartile range 8-30) Median Number of leftover pills 15 (interquartile range 3-26) Of those with leftovers pills 95% had not disposed of them at 2 weeks post-op Patterns of Opioid Prescription and Use After Cesarean Delivery Correlation between the larger of number pills dispensed and larger number consumed independent of patient characteristics # of pills dispensed did NOT correlate with patient satisfaction, pain control or need to refill prescription SHARED DECISION MAKING Leftover opioids from legitimate prescriptions represent a primary source of misused or diverted opioids. A shared decision-making approach to opioid prescribing after cesarean delivery was associated with approximately a 50% decrease in the number of opioids prescribed postoperatively in this cohort compared with our institutional standard prescription. This approach is a promising strategy to reduce the amount of leftover opioid medication after treatment of acute post cesarean pain. A Shared Decision-Making Intervention to Guide Opioid Prescribing After Cesarean Delivery ObstetGynecol 2017;130:42 6 3
4 RESPONSIBLE PRESCRIBING Cesarean Delivery is the most commonly performed inpatient surgical procedure in the United States Shared Decision Making - A Promising Strategy - 10 minutes, one day before discharge - Expected use - Patterns of pain - 50% decrease in number of opioids - Low refill rate - Risks and beneftis of opioid and non-opioid analgesics - Information on opioid disposal and access to refills CONTRACEPTION One Key Question All women age are asked One Key Question as a routine part of primary care: Would you like to become pregnant in the next year? Proactively address the root causes of poor birth outcomes and disparities in maternal and infant health. Oregon Foundation for Reproductive Health thenationalcampaign.org BREASTFEEDING Should be encouraged if no contraindications May reduce NAS symptoms Counsel about the need to suspend breastfeeding if relapse 4
5 OPIOID TASK FORCE REPRESENTATIVE JOHN NYGREN H.O.P.E. Heroin & Opioid Prevention and Education 2017 Special Session July 17, 2017 Governor Scott Walker signed into law 11 special session bills that are part of the Heroin, Opiate Prevention and Education (H.O.P.E.) Agenda. The bills were recommended by the Governor s Task Force on Opioid Abuse. Due to the leadership of Rep John Nygren, almost all bills were passed unanimously by both the State Senate and the Assembly Co-Chairs Report to Governor Cocaine Mom Law Jan 2018 Wisconsin s statute governing pregnant moms struggling with substance abuse needs to be revisited. This statute currently affects a number of stakeholders, and we intend to engage them in the coming months as we work towards a revised statute that maintains its core principles but improves its operation based on what we have learned in twenty years of experience and medical advances. Incarcerated Mothers Senate Bill 393 Stop Shackling of Pregnant Women Provide MAT Provide STI Screening and Treatment Provide Timely Prenatal Care Provide Doula Care *AWHONN POSITION STATEMENT March
6 References Opioid Use and Opioid Use Disorder in Pregnancy. Practice Bulletin 711. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;;130: Malavika Prabhu, MD, Emily McQuaid-Hanson, MD, Stephanie Hopp, MHS, MS, Sara M. Burns, MS, Lisa R. Leffert, MD, Ruth Landau, MD, Julie C. Lauffenburger, PharmD, PhD, NiteeshK. Choudhry, MD, PhD, Anjali Kaimal, MD, MAS, and Brian T. Bateman, MD, MScA Shared Decision-Making Intervention to Guide Opioid Prescribing After Cesarean Delivery Obstet Gynecol 2017;130:42 6. Uma M. Reddy, MD, MPH, Jonathan M. Davis, MD, ZhaoxiaRen, MD, PhD, and Michael F. Greene, MD, for the Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes Workshop Invited Speakers*. Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, andchildhoodoutcomes Executive Summary. Obstet Gynecol 2017;130: Pew Charitable Trust Presentation to the Governor s Task Force 6
Addressing the Opioid Crisis Policy Recommendations
Addressing the Opioid Crisis Policy Recommendations The Pew Charitable Trusts Pew is an independent nonprofit, nonpartisan research and policy organization. Tools: Research Partnerships Technical assistance
More informationCentral Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy
Centers for Disease Control and Prevention Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Jenna Meyer MPH, RNC-MNN, IBCLC Public Health Advisor Therapies for Opioid Dependent
More informationMultidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population
Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Dale Robinson MD,FACOG Jennifer Gonzalez RN,BSN Surgeon General s Report 2016 Office
More informationPublic Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids
Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Background The American Society of Addiction Medicine (ASAM) is deeply committed
More informationMANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling
MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin
More informationTHE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA
THE OPIOID CRISIS DEFINING THE CRISIS KATHLEEN DUPPER, MD MEDICAL DIRECTOR, HUNTSVILLE RECOVERY 19 th Annual Perinatal Conference: The Opioid Crisis September 21, 2018 DEFINING THE CRISIS NUMBER OF OPIOID-RELATED
More informationBuilding a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine
Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Scott M. Gagnon, MPP, PS-C Director, AdCare Educational Institute of Maine, Inc. Co-Chair, Prevention & Harm
More informationMaternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC
Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home
More informationADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians
ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of
More informationEI Leadership April 24, 2018
Early Childhood Community Partnerships to Support Families Struggling with SUD EI Leadership April 24, 2018 Setting the Stage The issue of young children impacted by substance use disorders in families
More informationDisclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond
Women and opioid use disorder: Optimizing care during pregnancy and beyond Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP Ashley L. Hodges, PhD, CRNP, WHNP-BC Disclosures Dr. Fogger has nothing to
More informationHOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89
HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89 In compliance with CMA regulation, I attest that I have no conflicts of interest associated
More informationPregnancy, Opioid Addiction, and Care Issues in Virginia
Pregnancy, Opioid Addiction, and Care Issues in Virginia Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia
More informationSuccessful Prevention Strategies to Address the Opioid Crises
Successful Prevention Strategies to Address the Opioid Crises Shannon Breitzman, MSW, Principal Denver Office Lindsey Kato, MPH, CHES, Consultant Denver Office 1 LEARNING OBJECTIVES + Find out how to effectively
More informationAddressing the Opioid Epidemic in Tennessee
Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationMaternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health
Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health Columbus, Ohio Assignment Description The rapid advance of the opiate crisis has had far
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationOpioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine
Opioid Use Disorders and Pregnancy Marcela Smid, MD Maternal-Fetal Medicine UNIVERSITY OF UTAH HEALTH, 2017 OBJECTIVES Definitions Epidemiology Pharmacology Effects on pregnancy Screening Treatment CARE
More informationLearning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons
Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Marianna Corona Jennifer Foley September 12, 2017 Learning Objectives 2017 Improving Family Outcomes
More informationMAT in the Corrections Setting
MEDICATION ASSISTED TREATMENT AND CORRECTIONS Frank Filippelli, DO, PhD September 2017 MAT in the Corrections Setting Who Does This Affect? What is MAT and What is the Evidence of Efficacy? Emphasis on
More informationOpioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard
Opioid Use in Pregnant Women and Prenatal Care Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Objectives Summarize contextual and co-morbid factors observed among
More informationOpioid use in pregnancy and Neonatal Abstinence Syndrome
Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,
More informationThe Opioid-Exposed Woman
The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus
More informationProduct Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD
1 The National Academies of Sciences, Engineering and Medicine Regulatory Strategies of address prescription opioidrelated harms 4 th of November, 2016 Washington DC Product Labeling to Communicate Benefits
More informationInterdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings
Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings BRIAN GARVEY, MD, MPH REBECCA CANTONE, MD OREGON HEALTH & SCIENCE UNIVERSITY SCAPPOOSE RURAL HEALTH CENTER Disclosures
More informationBuprenorphine Prescribing as a Patient- Centered Medical Home Enhancement
Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE
More informationMission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of
Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of amphetamines and opioids, both prescription and illicit, among
More informationClinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder
Clinical Guidelines for the Pharmacologic Treatment of Community Behavioral Health (CBH) is committed to working with our provider partners to continuously improve the quality of behavioral healthcare
More informationProtecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers
Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers Audio is streaming through your computer speakers. If you
More informationOregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models
Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections Framework and Response Models Oregon HIV, Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study
More informationMaternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015
Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples
More informationMaine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016
Maine s Response to the Opiate Crisis Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016 Required Disclosure Text Font typically Times New Roman at least 20 point Try
More informationAgenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model
Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased
More information2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society
Pregnant Women Who Use Drugs: Stigma, Science and Society Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia
More informationPennsylvania s Opioid Crisis: Data and Strategies to Combat It
Data and Strategies to Combat It May 8, 2018 Phillip M. Burrell Director, Research & Data Analytics The Hospital + Healthsystem Association of Pennsylvania Agenda The PA opioid crisis Trends Responses
More informationManaging drug misuse in pregnancy and beyond
Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management
More informationThe Impact of Addiction on Infant Mortality
Congressional Addiction, Treatment and Recovery Caucus and the Bipartisan Task Force to Combat the Heroin Epidemic Hosts: The Impact of Addiction on Infant Mortality Arthur R. James MD, FACOG Ohio State
More informationOUD & MAR: Caring for Our Communities
OUD & MAR: Caring for Our Communities Speaker: Elisabeth Fowlie Mock, MD, MPH Video Resources Diversion Alert/recoveryinme video https://www.youtube.com/watch?v=q1lsmwwwm40 CDC Videos RX Awareness Campaign
More information... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot
Department of... Health Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN Overview and Regional Snapshot Cynthia C. Thomas, DO, MPH, Assistant Health Officer, Northeast Regional Health
More informationEffects of Prenatal Illicit Drug. Use on Infant and Child
Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this
More informationWomen in the Opioid Crisis: Pain, Pregnancy and Life Course
Women in the Opioid Crisis: Pain, Pregnancy and Life Course Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics & Gynecology and Psychiatry Virginia Commonwealth University Addiction Medicine
More informationNeonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
More informationAnesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a
Appendix 1. Literature Search Databases Years Search Terms Pubmed 01/1966 1. Analgesics, Opioid a / or Opioid-related Disorders a / PsycINFO EMBASE Cochrane 09/2016 or Heroin a / or Heroin Dependence a
More information2/24/2014. Bridging the Gap Between Behavioral Health and Pregnancy. My Background and Interest in the Topic... Plan for Today
Bridging the Gap Between Behavioral Health and Pregnancy Amelia Mahan MSW, LCSW Behavioral Health Program Manager amahan@n3cn.org; (919) 926-3918 My Background and Interest in the Topic... Stumbled into
More informationINTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia
The American Journal on Addictions, 27: 92 96, 2018 Copyright 2018 American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12687 Brief Report: Treating Women
More informationMOMS Project Panel Overview
MOMS Project Panel Overview Rick Massatti, PhD, Ohio Department of Mental Health and Addiction Services Jennifer Bailit, MD, MetroHealth Medical Center Mike Marcotte, MD, Tri-Health Mona Prasad, DO,MPH,
More informationAddressing Substance Use Among Pregnant Women and New Moms
ADRIANA KOHLER AND KATE MURPHY SENIOR POLICY ASSOCIATES AKOHLER@TXCHILDREN.ORG KMUPRHY@TXCHILDREN.ORG MARCH 20, 2018 Addressing Substance Use Among Pregnant Women and New Moms Opportunities to Improve
More informationMassachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health
Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs Monica Bharel, MD MPH Commissioner of Public Health Data For Massachusetts 2017 Q2 Quarterly Report and Chapter 55
More informationMedication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers
Medication-Assisted Treatment & Pregnancy Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers Addiction/ Substance Use Disorder Addiction is a Biopsychosocial Disease Has
More informationMedication for the Treatment of Addiction (MAT)
Medication for the Treatment of Addiction (MAT) Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical College at Thomas Jefferson University Terminology: Words Matter Medication
More informationReferral to the Women s Alcohol and Drug Service (WADS) Procedure
1. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral is taken and processed. This includes the referral for clinical care
More informationTexas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome
Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome 1 Learning Objectives Become familiar with how the opioid epidemic is impacting Texas women Become familiar with Neonatal
More informationSupported by the Indiana Public Health Training Center. Welcome We will begin shortly
Supported by the Indiana Public Health Training Center Welcome We will begin shortly Public Health Insights and Innovations Self-Claim Attendance Please text code 42223 to 317-671-8998 to record your attendance
More informationMedication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment
Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin
More informationOpioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center
Opioid Use Disorder- Pregnancy Principles and Myths Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center History of NAS/NOWS Prior to 1875 infants not thought to be affected Congenital Morphinism
More informationTREATING OPIOID ADDICTION IN HOMELESS POPULATIONS
TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health
More informationAligning Pain Management Community Public Health Presentation
Aligning Pain Management Community Public Health Presentation Al Bliss, Health Educator La Crosse County Health Department 2016 Project Goal: (Community Public Health Session) Aligning Pain Care in Our
More informationContinuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment
Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment This webinar will be recorded and available on the NPIC/QAS website www.npic.org. Nurse Planner:
More informationState Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder
State Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder Wednesday, October 24, 2018 1:00-2:15pm ET Supported by the Health Resources and Services Administration
More informationOpioid Use Disorder in Pregnancy
Opioid Use Disorder in Pregnancy Hemant Satpathy, MD Evening of Perinatology November 5th, 2018 No Disclosures Objectives Identify the scope and prevalence of opioid use in pregnancy and the postpartum
More informationMaternal Mortality and Morbidity: The Role of Drug Overdoses
Maternal Mortality and Morbidity: The Role of Drug Overdoses Presentation to the House Select Committee on Opioids & Substance Abuse Lisa Hollier, M.D., M.P.H Chair, Maternal Mortality and Morbidity Task
More informationCONTINUING EDUCATION FOR PRESCRIBERS OF CONTROLLED SUBSTANCES. Statutory Provision S.L SECTION 11F.11.(a)
CONTINUING EDUCATION FOR PRESCRIBERS OF CONTROLLED SUBSTANCES Statutory Provision S.L. 2017-57 SECTION 11F.11.(a) Report to the Joint Legislative Oversight Committee on Health and Human Services By North
More informationPrenatal Substance Abuse: Improving Outcomes
Prenatal Substance Abuse: Improving Outcomes Jennifer Yates, MSN Family Nurse Practitioner Children s Hospital of Wisconsin Child Advocacy and Protection Services Overview Discuss the Problems Health,
More informationTaking Action Against Opioids through Research and Best Practice
Taking Action Against Opioids through Research and Best Practice Session 1002-7, March 6, 2018 Darshak Sanghavi, MD, Chief Medical Officer, OptumLabs Molly Jeffery, PhD, Scientific Director of Emergency
More informationBeyond Birth: A Comprehensive Recovery Center serving parenting women
Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The
More informationAdvancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance
Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical
More informationTaking Action Against Opioids through Research and Best Practice
Taking Action Against Opioids through Research and Best Practice Session 7, March 6, 2018 Darshak Sanghavi, MD, Chief Medical Officer, OptumLabs Molly Jeffery, PhD, Scientific Director of Emergency Care
More informationConfronting the Opioid Crisis at the State Level
Confronting the Opioid Crisis at the State Level The webinar has not yet begun. Audio will be available through the call-in information contained in your registration confirmation e-mail. Moderator: May
More information201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.
201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone. RELATES TO: KRS 311.530-311.620, 311.990 STATUTORY AUTHORITY: KRS
More informationOn December 27, 2017, the Lieutenant Governor signed into law several new requirements
OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following
More information(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)
Buprenorphine Initiation and Maintenance in Pregnancy (Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Assessment The diagnosis of OUD should be confirmed by DSM-5
More informationJohann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works
From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a
More informationChild Welfare and MOMS: Building Partnerships to Improve Care
Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National
More informationPROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN
PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN 1 OPIOID USE DISORDER IN WOMEN Recognition & Prevention Date: August 14 th, Time: 8 am Presenters: Deepa Nagar MD, Andria Peterson PharmD Maternal Treatment
More informationUse of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH
Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH University of Pittsburgh Medical Center Disclosures Presenter has no financial interests to
More informationThe Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010
The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 EXECUTIVE SUMMARY It is well documented in multiple
More informationOPIOID MICRO TRAINING MODULE 4: UNDERSTANDING OPIOID USE, PREGNANCY, AND NEONATAL ABSTINENCE SYNDROME (NAS)
OPIOID MICRO TRAINING MODULE 4: UNDERSTANDING OPIOID USE, PREGNANCY, AND NEONATAL ABSTINENCE SYNDROME (NAS) This training is offered by the Florida Alcohol and Drug Abuse Association and JBS International.
More informationScience = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse
Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater
More informationConsequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018
Consequences and Treatment of Opioid Abuse During Pregnancy Katie Ellis, PharmD March 12, 2018 Disclosure I have nothing to disclose. Objectives At the completion of this activity, the pharmacist will
More informationMedication-assisted opioid addiction treatments: OB/GYN
5/13/16se Medication-assisted opioid addiction treatments: OB/GYN In October 2002, the Food and Drug Administration (FDA) approved buprenorphine monotherapy product, Subutex, and a buprenorphine/naloxone
More informationReferral to the Women s Alcohol and Drug Service (WADS) Procedure
Procedure Referral to the Women s Alcohol and Drug Service (WADS) Procedure. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral
More informationPotential Solutions to Epidemic Substance Abuse in US and Europe
Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine
More informationReducing Maternal Mortality & Morbidity Surveillance & Action
Reducing Maternal Mortality & Morbidity Surveillance & Action Marilyn Kacica, MD, MPH Medical Director Division of Family Health February 14, 2018 February 14, 2018 2 Presentation Overview Surveillance
More informationAddressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust
Addressing Prescription Drug Abuse Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Outline 1. Prescription Drug Monitoring Programs 2. Federal policy landscape including
More informationJerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry
Jerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry Acknowledgements Funding for this work has come from: The Staunton Farm Foundation
More informationThe Substance Exposed Newborn Alphabet Soup
The Substance Exposed Newborn Alphabet Soup SEN, NAS, NOWS, OUD, SUD & MAT Sara Park MD Chief Medical Officer Comprehensive Medical and Dental Program Department of Child Safety CAP conference, July 2017
More information6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES
First Do No Harm Implementing an Opioid Stewardship Program in a HealthCare System Phil Chang, MD Kristy Deep, MD Doug Oyler, PharmD June 12, 2017 OBJECTIVES Explain the role of opioid stewardship as a
More informationVermont Guidelines for Obstetric Providers
Vermont Guidelines for Obstetric Providers VERMONT GUIDELINES FOR OBSTETRIC PROVIDERS Overview... 1 Opioid Maintenance During Pregnancy... 1 medication and treatment setting options... 1 Methadone... 2
More informationOpioid Use Disorder Treatment Initiation in Diverse Settings
Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures
More informationAddressing The Opioid Epidemic: An Evidence-Based Approach
Addressing The Opioid Epidemic: An Evidence-Based Approach Translating Research And Policy Into Practice 2018 Missouri Rural Health Conference August 22, 2018 1-2pm Distribution of Drug-Induced Deaths
More informationINTERVENTIONS TO SUPPORT BREASTFEEDING IN WOMEN ON OPIOID MAINTENANCE THERAPY: A SYSTEMATIC REVIEW. Meg Doerzbacher RN, MS, NNP-BC
INTERVENTIONS TO SUPPORT BREASTFEEDING IN WOMEN ON OPIOID MAINTENANCE THERAPY: A SYSTEMATIC REVIEW Meg Doerzbacher RN, MS, NNP-BC 1 Background Increased prevalence of opioid use disorder Increased incidence
More informationMorrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence
Morrison County Community-Based Care Coordination Our Core Values Reverence Integrity Compassion Excellence Community Based Care Coordination Project The goal is to mitigate the need for, overuse of, and
More informationOpiate Use in Reproductive Age Females
Opiate Use in Reproductive Age Females February 15, 2017 2:00 pm-3:00 pm ET In order to hear the presentation please call +1 (562) 247-8422, access code 579-542-512 All Participant Phone Lines are Muted
More informationAddiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018
Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Fear Shame Commitment Barriers Opportunities Fear Thalidomide induced phocomelia 1957 Fear Fetal Alcohol
More information9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment
Postpartum Counseling for Women in MAT Katie Clark MSPH, CSAC A little about Katie SUD and PH crossroads BA Health Arts and Sciences Goddard College MSPH MCH UNC Project Lazarus, Yale, CHER Solutions LLC
More informationStructured Guidance for Postpartum Retention in HIV Care
An Approach to Creating a Safety Net for Individual Patients and for Programmatic Improvements 1. Problem statement and background: Pregnant women living with HIV (WLH) are a vulnerable population that
More informationThe Substance Exposed Newborn Standards of Care
The Substance Exposed Newborn Standards of Care Sara Park MD Chief Medical Officer Comprehensive Medical and Dental Program Department of Child Safety CAP conference, July 2017 Disclosures I have no financial
More information